RaQualia Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 16 shareholders own 27.23% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11%	Yuichi Kakinuma	2,384,700	JP¥1.4b	0%	no data
3.44%	Pfizer Inc.	743,000	JP¥449.1m	0%	no data
2.89%	Heights Capital Management, Inc.	625,000	JP¥377.8m	0%	1.38%
1.99%	SBI Holdings Inc., Asset Management Arm	430,553	JP¥260.2m	0%	0.1%
1.32%	Ueda Yagi Tanshi Co. Ltd., Asset Management Arm	286,000	JP¥172.9m	0%	0.2%
1.25%	The Tokyo Tanshi Co., Ltd., Asset Management Arm	270,200	JP¥163.3m	0%	1.85%
1.04%	Advanced Media, Inc.	223,800	JP¥135.3m	0%	no data
0.95%	S.B.C Co.,Ltd.	205,800	JP¥124.4m	14.4%	no data
0.93%	au Kabucom Securities Co., Ltd., Asset Management Arm	201,560	JP¥121.8m	0%	0.49%
0.83%	Takahiro Tanago	180,200	JP¥108.9m	2.56%	no data
0.67%	Yukio Uemura	145,400	JP¥87.9m	-0.21%	no data
0.63%	Ikuyoshi Komoto	137,000	JP¥82.8m	0%	no data
0.084%	State Street Global Advisors, Inc.	18,100	JP¥10.9m	-13.4%	no data
0.078%	Masaki Sudo	16,847	JP¥10.2m	32.2%	no data
0.052%	Hirobumi Takeuchi	11,331	JP¥6.8m	109%	no data
0.039%	Katsuhiro Uto	8,454	JP¥5.1m	94.2%	no data